Success of Current COVID-19 Vaccine Strategies vs. the Epitope Topology of SARS-CoV-2 Spike Protein-Receptor Binding Domain (RBD): A Computational Study of RBD Topology to Guide Future Vaccine Design (original ) (raw )Variety of Spike Protein in COVID-19 Mutation: Stability, Effectiveness and Outbreak Rate as a Target for Vaccine and Therapeutic Development
azam ghadami
Biointerface Research in Applied Chemistry, 2020
View PDFchevron_right
Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding
Konstantin Shaitan
Viruses
View PDFchevron_right
Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach
Nouman Ali
2023
View PDFchevron_right
In Silico Approach to Construct the 3D Structures of Spike Glycoproteins of Novel Variants of Severe Acute Respiratory Syndrome Coronavirus 2
Dr. Shalini Swami
Zenodo (CERN European Organization for Nuclear Research), 2023
View PDFchevron_right
SARS-CoV-2 mutations and where to find them: an in silico perspective of structural changes and antigenicity of the spike protein
Ubiratan Batista
Journal of biomolecular structure & dynamics, 2020
View PDFchevron_right
Mutational landscape and in silico structure models of SARS-CoV-2 spike receptor binding domain reveal key molecular determinants for virus-host interaction
Roshny Prasad
BMC Molecular and Cell Biology, 2022
View PDFchevron_right
SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern
Silvia Pavoni
Journal of Chemical Information and Modeling
View PDFchevron_right
Multi-epitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An In Silico Analysis
Kruapnidhi Sreerama
View PDFchevron_right
Using In Silico Bioinformatics Algorithms for the Accurate Prediction of the Impact of Spike Protein Mutations on the Pathogenicity, Stability, and Functionality of the SARS-CoV-2 Virus and Analysis of Potential Therapeutic Targets
negin alizadeh
Biochemical Genetics
View PDFchevron_right
High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients
Katherine Candray
Microbiology spectrum, 2021
View PDFchevron_right
Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach
udit saumya
Expert Review of Vaccines, 2020
View PDFchevron_right
Mutations in Spike Protein of SARS-CoV-2 Modulate Receptor Binding, Membrane Fusion and Immunogenicity: An Insight into Viral Tropism and Pathogenesis of COVID-19
Ranabir Majumder
View PDFchevron_right
Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2)
subham biswal
PeerJ
View PDFchevron_right
Computational simulation of interactions between SARS coronavirus spike mutants and host species-specific receptors
Masami Hasegawa
Computational Biology and Chemistry, 2007
View PDFchevron_right
Structural basis to design multi-epitope vaccines against Novel Coronavirus 19 (COVID19) infection, the ongoing pandemic emergency: an in silico approach
mohit kamthania
View PDFchevron_right
Structural and energetic profiling of SARS-CoV-2 antibody recognition and the impact of circulating variants
Ghazaleh Taherzadeh
2021
View PDFchevron_right
In silico analysis of SARS-CoV-2 spike glycoprotein and insights into antibody binding
Victor Padilla-Sanchez, PhD
Research Ideas and Outcomes
View PDFchevron_right
Mutational analysis of the spike protein of SARS-COV-2 isolates revealed atomistic features responsible for higher binding and infectivity
Muqaddas Fatima
Frontiers in Cell and Developmental Biology
View PDFchevron_right
In silico Antibody Mutagenesis for Optimizing its Binding to the Spike Protein of SARS-CoV-2
Binquan Luan
2020
View PDFchevron_right
Homology Modeling and Molecular Dynamics-Driven Search for Natural Inhibitors That Universally Target Receptor-Binding Domain of Spike Glycoprotein in SARS-CoV-2 Variants
Wojciech Kolodziejczyk
Molecules
View PDFchevron_right
In Silico Comparative Analysis of the Functional, Structural, and Evolutionary Properties of SARS-CoV-2 Variant Spike Proteins
Palaksha K. Javaregowda
JMIR Bioinformatics and Biotechnology
View PDFchevron_right
Unraveling the stability landscape of mutations in the SARS-CoV-2 receptor-binding domain
Hamdi Yahyaoui
Scientific Reports, 2021
View PDFchevron_right
Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses
Tom Blundell
2021
View PDFchevron_right
Targeting Receptor Binding Domain and Cryptic Pocket of Spike glycoprotein from SARS-CoV-2 by biomolecular modeling
Frida Sosa Amay
arXiv: Biomolecules, 2020
View PDFchevron_right
Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19
Mohan Singh
Journal of Chemical Neuroanatomy, 2020
View PDFchevron_right
Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19
golnaz bahramali
Molecular Biotechnology, 2021
View PDFchevron_right
In silico design of Multi-epitope-based peptide vaccine against SARS-CoV-2 using its spike protein
Janmejay Pandey
View PDFchevron_right
Identification of a Potent Inhibitor Targeting the Spike Protein of Pandemic Human Coronavirus, SARS-CoV-2 by Computational Methods
Sruthi Unni
View PDFchevron_right
Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach
Meena Pal
VirusDisease, 2021
View PDFchevron_right
Functional and Structural Characterization of SARS-Cov-2 Spike Protein: An In Silico Study
Meysam Hasannejad-Bibalan
Ethiopian Journal of Health Sciences
View PDFchevron_right
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
Krishna Anand
2021
View PDFchevron_right
Distinct evolution of infection-enhancing and neutralizing epitopes in the spike protein of SARS-CoV-2 variants (alpha, beta, gamma, delta, lambda and mu) : a structural and molecular epidemiology study
Jacques Fantini
2021
View PDFchevron_right